TAKING A CLOSER LOOK AT VACCINE EXPORTS

TAKING A CLOSER LOOK AT VACCINE EXPORTS

News
WEEKLY COVID VACCINE RESEARCH UPDATE Friday, July 9, 2021 High-income country confirmed dose total: 6.2 billion Upper-middle-income country total: 2.3 billion Lower-middle-income country total: 1.9 billion Low-income country total: 306 million COVAX total: 3.1 billion Total worldwide confirmed purchases of Covid-19 vaccines: 12.9 billion doses INSIGHTS Taking a closer look at vaccine exports Author: Joslin Coggan Many countries in Africa, Asia, and Latin America have yet to receive the vaccines necessary to slow the spread of Covid-19 despite recent purchase and donation agreements. In recent weeks, large scale donations of Covid-19 vaccines have made headlines as the US and EU promised to send hundreds of millions of doses to low- and middle-income countries (LMICs). However, many of these deals are yet to be realized as exports have not matched demand. Supply…
Read More
THE G7 UNDERWHELMS, WITH NUMBERS THAT DON’T ADD UP

THE G7 UNDERWHELMS, WITH NUMBERS THAT DON’T ADD UP

News
WEEKLY COVID VACCINE RESEARCH UPDATE Friday, June 18, 2021 High-income country confirmed dose total: 6 billion Upper-middle-income country total: 2.2 billion Lower-middle-income country total: 1.8 billion Low-income country total: 271 million COVAX total: 2.4 billion Total worldwide confirmed purchases of Covid-19 vaccines: 12.7 billion doses INSIGHTS The G7 underwhelms, with numbers that don’t add up Author: Andrea Taylor The G7 began their much-anticipated summit last week with a target to reach 1 billion doses of Covid-19 vaccine in pledged donations for low- and middle-income countries (LMICs). The result could be described as underwhelming (as well as unclear). To be fair, the US set a high bar early in the week, with a plan to donate 500 million Pfizer-BioNTech doses (working “with,” but not necessarily through, COVAX). It was going to be…
Read More
HOW CAN INDIA ADDRESS A POTENTIAL THIRD WAVE OF SARS-CV-2 INFECTIONS?

HOW CAN INDIA ADDRESS A POTENTIAL THIRD WAVE OF SARS-CV-2 INFECTIONS?

News
WEEKLY COVID VACCINE RESEARCH UPDATE Friday, June 11, 2021 High-income country confirmed dose total: 6 billion Upper-middle-income country total: 2.2 billion Lower-middle-income country total: 1.4 billion Low-income country total: 271 million COVAX total: 2.4 billion Total worldwide confirmed purchases of Covid-19 vaccines: 12.2 billion doses INSIGHTS How can India address a potential third wave of SARS-CoV-2 infections? Author: Nikki Prattipati Starting mid-March 2021, India has become the epicenter of COVID-19 as a second wave of infections devastated the country. India reported 50 percent of global cases and 30 percent of global COVID-19 deaths, and an alarming rate of over 400,000 daily new cases at the height of the wave in early May 2021. While official projections estimate 29 million total infections and 360,000 deaths, low testing rates and the lack of available data lead some…
Read More
HOW DO COVID-19 VARIANTS IMPACT VACCINATIONS AND THE ABILITY TO END THE ACUTE PHASE OF THE PANDEMIC?

HOW DO COVID-19 VARIANTS IMPACT VACCINATIONS AND THE ABILITY TO END THE ACUTE PHASE OF THE PANDEMIC?

News
WEEKLY COVID VACCINE RESEARCH UPDATE Friday, June 4, 2021 [caption id="attachment_1629" align="alignnone" width="300"] Coronavirus and DNA, virus mutation. New variant and strain of SARS CoV 2. Microscopic view. 3D rendering[/caption] High-income country confirmed dose total: 6 billion Upper-middle-income country total: 2.2 billion Lower-middle-income country total: 1.1 billion Low-income country total: 270 million COVAX total: 2.4 billion Total worldwide confirmed purchases of Covid-19 vaccines: 11.9 billion doses INSIGHTS How do COVID-19 variants impact vaccinations and the ability to end the acute phase of the pandemic? Author: Blen Biru Multiple COVID-19 genetic variants have been detected since the initial SARS-CoV-2 strain was found in China, the most significant of which are classified by the WHO as variants of concern or variants of interest, depending on their attributes and risk level. The variants of concern are…
Read More
IS VACCINE TOURISM ETHICAL?

IS VACCINE TOURISM ETHICAL?

News
WEEKLY COVID VACCINE RESEARCH UPDATE Friday, May 28, 2021 High-income country confirmed dose total: 5.9 billion Upper-middle-income country total: 1.8 billion Lower-middle-income country total: 961 million Low-income country total: 270 million COVAX total: 2.4 billion Total worldwide confirmed purchases of Covid-19 vaccines: 11.3 billion doses INSIGHTS Is vaccine tourism ethical? Author: Blen Biru According to Our World in Data, 1.78B people are fully vaccinated against COVID-19 across the world. About 16% of the fully vaccinated (289M people) live in the US, which has a very high rate of vaccination, especially compared to neighboring countries in Latin America. The abundance of available vaccines in the US has attracted foreign travelers from South America and other parts of the world looking to get vaccinated, referred to as vaccine tourism. An estimated 70,000 people from…
Read More
WHAT THE MANUFACTURING LANDSCAPE CAN TELL US NOW

WHAT THE MANUFACTURING LANDSCAPE CAN TELL US NOW

News
WEEKLY COVID VACCINE RESEARCH UPDATE Saturday, May 15, 2021 INSIGHTS What the manufacturing landscape can tell us now Author: Andrea Taylor Manufacturing projections for Covid-19 vaccines seem to shift on a near-weekly basis. We are not even halfway into 2021 and already we have seen adjustments, both up and down, across all vaccine makers. 2021 projections differ by vaccine platform Overall, we see 2021 projections increasing for mRNA vaccines Pfizer-BioNTech and Moderna, while decreasing for viral vector vaccines Oxford-AstraZeneca and Janssen (J&J). AstraZeneca, in particular, has faced significant manufacturing issues throughout its global production network. In addition to the well-covered constraints slowing down manufacturing in Europe and the Serum Institute of India, partners in Mexico, Brazil, and elsewhere have struggled to get production started or sustained. Janssen’s vaccine has also experienced setbacks, including the temporary…
Read More
THE GLOBAL PICTURE OF COVID-19 VACCINE APPROVALS

THE GLOBAL PICTURE OF COVID-19 VACCINE APPROVALS

News
WEEKLY COVID VACCINE RESEARCH UPDATE Friday, April 16, 2021 High-income country confirmed dose total: 4.7 billion Upper-middle-income country total: 1.5 billion Lower-middle-income country total: 731 million Low-income country total: 770 million COVAX total: 1.12 billion Total worldwide confirmed purchases of Covid-19 vaccines: 8.9 billion doses INSIGHTS The global picture of Covid-19 vaccine approvals Author: Blen Biru COVID-19 vaccines across the world have been produced and authorized for use with record speed. So far, 13 vaccines have received either limited or full regulatory approval. It’s important to note that the safety of the vaccines is continuously monitored even after limited and full regulatory approvals are granted. The recent post-approval regulatory revisions and suspensions of Oxford-AstraZeneca and J&J demonstrate the continuous monitoring efforts by regulatory bodies. To highlight the importance of regulatory…
Read More
Partnering to Scale Impact

Partnering to Scale Impact

News
The saying “two minds are better than one” rings especially true in the field of global health innovation. For grantees and finalists of the Saving Lives at Birth (SL@B) program, the DevelopmentXChange (DevX) is an annual event that brings together innovative minds from across the world, producing excellent opportunities for partnership development. From partnerships with peer-innovators with complementary technologies, to investors and distributors, SL@B innovators have made a wide range of connections by attending DevX. The event provides interactive workshops, mentorship and partnership meetings, and ample networking opportunities, including an Innovation Marketplace where all innovators can showcase their projects. Through these elements, DevX fosters a collaborative atmosphere that has contributed to the successful development of numerous partnerships. While the types of collaborations are diverse, there are common themes in how…
Read More